Inhalation anesthesia using physiologically based pharmacokinetic models.

[1]  P O Droz,et al.  Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. , 1989, British journal of industrial medicine.

[2]  E. Eger,et al.  Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans? , 1987, Anesthesia and analgesia.

[3]  P O Droz,et al.  Human styrene exposure , 1983, International archives of occupational and environmental health.

[4]  B. Škerlj.  Age changes in fat distribution in the female body. , 1959, Acta anatomica.

[5]  E. Eger,et al.  Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. , 1989, Anesthesia and analgesia.

[6]  Edmond I. Eger,et al.  Comparison of Kinetics of Sevoflurane and Isoflurane in Humans , 1992 .

[7]  E. Eger,et al.  Pharmacokinetics of Inhaled Anesthetics in Humans: Measurements during and after the Simultaneous Administration of Enflurane, Halothane, Isoflurane, Methoxyflurane, and Nitrous Oxide , 1986, Anesthesia and analgesia.

[8]  G. Levy,et al.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man , 1972, Clinical pharmacology and therapeutics.

[9]  K. Fish,et al.  Halothane Inhibits Metabolism of Enflurane in Fischer 344 Rats , 1983, Anesthesiology.

[10]  V. Fiserova-Bergerova.  Inhibitory Effect of Isoflurane upon Oxidative Metabolism of Halothane , 1984, Anesthesia and analgesia.

[11]  V. Fiserova-Bergerova,et al.  Predictable "individual differences" in uptake and excretion of gases and lipid soluble vapours simulation study. , 1980, British journal of industrial medicine.

[12]  V Fiserova-Bergerova.  Application of toxicokinetic models to establish biological exposure indicators. , 1990, The Annals of occupational hygiene.

[13]  E. Eger,et al.  The Extent of Metabolism of Inhaled Anesthetics in Humans , 1986, Anesthesiology.

[14]  R. Weiskopf,et al.  Kinetics of desflurane, isoflurane, and halothane in humans. , 1991, Anesthesiology.

[15]  D. F. Dolan,et al.  Transient Inhibitory Effect of Isoflurane upon Oxidative Halothane Metabolism , 1985, Anesthesia and analgesia.

[16]  K. Singhal,et al.  Simulation and prediction of uptake, distribution, and exhalation of organic solvents , 1974, British journal of industrial medicine.

[17]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.

[18]  P. Mozzo,et al.  Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. , 1986, British journal of industrial medicine.

[19]  V. Fiserova-Bergerova,et al.  Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. , 1984, Drug metabolism reviews.

[20]  V. Fiserova-Bergerova.  Toxicokinetics of organic solvents. , 1985, Scandinavian journal of work, environment & health.

[21]  A. Keys,et al.  Body fat in adult man. , 1953, Physiological reviews.

[22]  D. Holaday,et al.  Uptake and clearance of inhalation anesthetics in man. , 1979, Drug metabolism reviews.

[23]  D J Paustenbach,et al.  Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model. , 1987, American Industrial Hygiene Association journal.